Clinical Trials Logo

Keratitis clinical trials

View clinical trials related to Keratitis.

Filter by:

NCT ID: NCT04213885 Recruiting - Bacterial Keratitis Clinical Trials

Safety and Effectiveness of the PXL Platinum 330 System for Corneal Collagen Cross-Linking in Eyes With Corneal Thinning Position

Start date: May 4, 2020
Phase: Phase 2
Study type: Interventional

To determine whether the Peschke PXL-330 is safe and effective in the treatment of corneal thinning conditions.

NCT ID: NCT04075669 Recruiting - Corneal Ulcer Clinical Trials

Multiplex Strip Polymerase Chain Reaction for Diagnosis of Eye Infection Diseases From Corneal Scraping Samples

Start date: August 1, 2019
Phase:
Study type: Observational

The aim of this study is to see if multiplex strip PCR will detect the pathogen that causing eye infection from the corneal scraping samples with higher sensitivity and specificity than the current gold standard.

NCT ID: NCT03918408 Recruiting - Bacterial Keratitis Clinical Trials

Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Collagen Cross-Linking in Eyes With Corneal Thinning Conditions

Start date: September 1, 2019
Phase: Phase 1
Study type: Interventional

To determine whether the Peschke PXL-330 system is safe and effective in the treatment of corneal thinning conditions.

NCT ID: NCT03652415 Recruiting - Dry Eye Clinical Trials

DRy Eye Outcome and Prescription Study

DROPS
Start date: August 23, 2018
Phase:
Study type: Observational [Patient Registry]

The DRy eye Outcome and Prescription Study (DROPS) is a large observational multicentre study exploring the 'real world' effectiveness of artificial tears in dry eye disease and determinants of efficacy. The aim is to include at least 635 symptomatic dry eye patients who are prescribed artificial tears. All trainees and fellows in London are invited to become collaborators: collaborators are asked to consent patients, assess signs at baseline, and give patients questionnaires at baseline and 4 weeks (for home completion). In tandem, we are conducting a qualitative review of ophthalmologists' prescribing behaviours for dry eye disease.

NCT ID: NCT03230058 Recruiting - Infection, Fungal Clinical Trials

Combination Treatment of 5% Natamycin and 1% Voriconazole in Fungal Keratitis

NATA_VORI
Start date: January 1, 2017
Phase: Phase 2/Phase 3
Study type: Interventional

OBJECTIVE To evaluate the efficacy and safety of the concurrent treatment of 5% Natamycin and 1% Voriconazole in patients affected by fungal keratitis METHODS AND MATERIALS STUDY POPULATION Patients with smear and or culture proven fungal keratitis presenting to our Instituts, were eligible for enrollment. STUDY DESIGN Prospective double masked randomized clinical trial.

NCT ID: NCT03217474 Recruiting - Clinical trials for Herpes Simplex Keratitis

Femtosecond Laser-assisted Corneal Debridement for Herpes Simplex Keratitis

Start date: July 20, 2017
Phase: N/A
Study type: Interventional

The purpose of the study is to learn if adding femtosecond laser-assisted corneal debridement to a standard therapy of oral ganciclovir can help shorten the healing time of herpes simplex epithelial keratitis (HSK).

NCT ID: NCT03013959 Recruiting - Keratitis, Herpetic Clinical Trials

Observation on the Herpes Simplex Keratitis

OHSV
Start date: November 2016
Phase: N/A
Study type: Observational [Patient Registry]

As is reported, NSAIDs(pranoprofen ,bromfenac) eye drops can suppress herpes simplex virus(HSV-1) reactivation and reduce inflammatory reaction in vitro and in vivo. In Clinical, there is no risk of corneal tissue melting, glaucoma, cataract by topical application of NSAIDs. To explore more effective clinical treatment of viral keratitis patients to control the inflammatory damage, save the visual function and reduce the recurrence of the virus ,we observe the effect of anti-inflammatory and inhibition of recurrence on the herpes simplex virus after topical NSAIDs administration.

NCT ID: NCT02865876 Recruiting - Keratitis Clinical Trials

Effectiveness of Corneal Accelerated Crosslinking for Infectious Keratitis

Start date: June 2015
Phase: Phase 3
Study type: Interventional

The objective of this study is to evaluate the efficacy and safety of accelerated cross-linking (Avedro Inc., Waltham, USA) in the management of microbial keratitis as adjunctive therapy.

NCT ID: NCT02826174 Recruiting - Corneal Ulcer Clinical Trials

Topical Anesthesia for Closed PKP vs Retrobulbar Anesthesia for Open-sky PKP

Start date: December 2015
Phase: N/A
Study type: Interventional

Penetrating keratoplasty (PKP) is an open-sky surgery that fundamentally has not changed for more than 100 years. Because conventional PKP is associated with the potential for the development of devastating complications such as expulsive suprachoroidal hemorrhage and endophthalmitis, we modified the technique to one that is a closed surgery under topical anesthesia with the anterior chamber maintained to achieve favorable results. Topical anesthesia is an attractive alternative to traditional injection local anesthesia since the potentially serious complications associated with retrobulbar and peribulbar anesthesia can be avoided. The closed PKP procedure with the stable anterior chamber essentially changes the open nature of conventional PKP. The advantages, i.e., decreased surgical risks, postoperative complications, and surgical difficulties, make PKP viable in most complicated cases.

NCT ID: NCT02763605 Recruiting - Clinical trials for Acanthamoeba Keratitis

Retrospective Study of Acanthamoebic Keratitis During the Past 10 Years

Start date: January 2014
Phase: N/A
Study type: Observational

Acanthamoebic keratitis is an important corneal disease which may cause severe complication. The difficulty in diagnosis, the difficulty in treatment, and the long treatment process are factors leading to the poor prognosis of these patients. In this retrospective study, the investigators try to analyze the tissue proven Acanthamoebic keratitis diagnosed in our hospital. The investigators will focus on the in vivo confocal microscopic results, the medical history and the medical/surgical treatment outcome. The investigators will collect the tissue proven cases according to the data provided by laboratory diagnosis department and pathological department. The in vivo confocal microscopic results will be collected and analyzed. The investigators will also look through the photography of the external eyes from data stored in PAC system. The medical history and treatment outcome will be studied from clinical chart review. From this study, the investigators aimed to find out a easy way of diagnosing Acanthamoebic keratitis from in vivo confocal microscopy, and find out a better way for treatment.